In short
A personalised plan is not a longer list of tests. It is a shorter one, chosen because your risk band and your risk enhancers make those specific tests worth doing.
Four things personalise it.
- Your risk band, which determines whether medication is warranted at all
- Your risk enhancers, the factors your calculator leaves out
- Your age, which sets both the screening list and the review interval
- What you will actually do, since a plan you do not follow has no effect size
Treatment Overview
What actually makes a plan personal?
Not a longer panel. The four inputs that change the plan are your calculated risk band, the enhancers your calculator omits, your age, and what you will realistically sustain.
How the risk band decides the plan
| Under 3 per cent | Lifestyle. Most people gain nothing from medication. Reassess in four to six years. A calcium score is not recommended, as it rarely reclassifies anyone. |
| 3 to under 5 per cent | The genuinely uncertain group. Risk enhancers and lifetime risk are weighed, and a calcium score frequently settles it. |
| 5 to under 10 per cent | Statin usually suggested, more strongly at the top of the range. A calcium score is reasonable if you would rather avoid medication. |
| 10 per cent or more | Treat. No further stratification is needed. |
Why the same test is right for one person and wrong for another
Take a calcium score. At low risk it is not recommended, because it is unlikely to move you into a higher category. At borderline risk it often changes the decision in either direction.
And if your LDL is already 190 or above, it is generally not done at all, because treatment is indicated regardless of the result.
What are risk enhancers and why do they matter here?
They are factors that raise your real risk but sit outside some calculators. They do not change the number, they change how the number is read, and they are decisive precisely at borderline and intermediate risk.
In diabetes the recognised ones are duration of 10 years or more for type 2 and 20 for type 1, albuminuria, kidney function below 60, retinopathy and neuropathy.
Why age shapes the plan more than anything else
- 20 to 29: risk is discussed and factors identified, but calculators are not routinely used, because absolute risk is very low and estimation is unreliable
- 30 to 79: quantitative risk calculation, with lifetime risk added between 30 and 59 when the 10 year figure is low or borderline
- Over 79: individualised. Age dominates the calculation, so most people land at intermediate risk regardless, and calculators may overestimate
Where the plan comes from a conversation rather than a number
Risk thresholds are used first to open a discussion, not to dictate. People have different thresholds for taking daily medication, and that is a legitimate input rather than a failure of compliance.
Risks are given in absolute terms, because absolute numbers are understood better than relative ones and people consistently overestimate benefit and underestimate harm.
Who Is a Good Candidate?
- You have results but no plan, or a plan nobody explained
- Your calculated risk came out borderline and you were left to decide alone
- You have diabetes, kidney disease or an autoimmune condition that standard calculators handle poorly
- You would rather avoid daily medication and want to know whether that is reasonable for you
- You want the plan to fit the life you actually have
- Established cardiovascular disease, where the plan is secondary prevention rather than risk estimation
- LDL cholesterol of 190 mg/dL or above, which needs treating and assessment for an inherited cause
- An active symptom, which needs a diagnosis before a prevention plan
What Happens During the Consultation
-
1
Where you actually are
Calculated 10 year risk, plus 30 year risk between 30 and 59 where the 10 year figure is low or borderline. A low 10 year risk with a lifetime risk of 10 per cent or more changes the conversation.
-
2
What the calculator missed
Risk enhancers, family history with ages attached, and in diabetes the duration, albuminuria, kidney function, retinopathy and neuropathy. These adjust the reading rather than the number.
-
3
Only the tests that would change something
A calcium score where the decision is genuinely uncertain. No score at low risk, and none when LDL is already 190 or above, because treatment is indicated either way.
-
4
A plan you have agreed to
Named medication or no medication, named targets, two or three behaviour changes with numbers, and a review interval. Your own threshold for taking medication is part of the decision.
Program Structure & Follow-Up
How the plan runs over time
| Low risk | Reassess in four to six years, sooner if a risk factor changes such as new hypertension |
| Borderline | Yearly reassessment is reasonable |
| Intermediate | Yearly measurement and discussion of risk reduction |
| On new medication | Sooner, for monitoring and adjustment |
What triggers an early review
- A new diagnosis: hypertension, diabetes, kidney disease
- A change in medication
- A new symptom, particularly on exertion
- A family diagnosis that changes your history
What is deliberately not repeated
Calcium scoring is not repeated to see whether treatment is working, because progression adds little to what the first scan told you. If your score was zero, a repeat at three to seven years is reasonable only where it would change a decision.
When targets change
If plaque is found, the targets tighten. A score of 100 to 299 brings an LDL goal under 70 mg/dL, and 300 or more a goal under 55 mg/dL, which are the targets used for people with known heart disease.
Benefits, Limits & Safety
What personalisation actually achieves
Fewer people on medication who would not benefit, and fewer people missed who would. Both errors are common when a single threshold is applied to everyone.
It also changes who gets reassured. A calcium score of zero is the strongest de risking result available, and for the right person it is a reason not to start treatment.
Where personalisation reaches its limits
- Calculators estimate the average risk of people like you, not your risk. That is a real limitation, not a technicality
- External validation is imperfect. In one study across four health systems, a newer model underestimated observed incidence in three of them
- Evidence for acting on 30 year risk alone is limited, and that is stated when it is used
- Breast cancer risk tools are inaccurate for women with several affected first degree relatives
What does not personalise a plan
A longer test list, a biological age score, a consumer genomic panel, or a tier of membership. None of these has been shown to change outcomes, and each adds results that need chasing.
What if you decline treatment?
That is a legitimate decision, provided it is informed. Where the choice is genuinely balanced you will be told that it is balanced, and the plan then focuses on what you are willing to do rather than on what you declined.
What a real plan contains
A risk band, named targets, a decision on medication either way, two or three behaviour changes with numbers, and a review date.
Intervals set by risk
Four to six years if low, yearly at borderline or above, sooner if a risk factor changes or medication is started.
What is left out
Tests that would not change anything, repeat calcium scoring to monitor treatment, biological age scores and consumer genomic panels.
Cost & Program Investment
The consultation is quoted individually and every test is quoted before it is ordered, so the total is known in advance. There is no plan tier and no membership, because the right plan depends on your risk band rather than on what you are willing to spend. Where a test would not change anything for you, you are told so and it is left out.
Frequently Asked Questions
Your calculated risk band, the risk enhancers your calculator omits, your age, and what you will realistically sustain. Those four inputs change the plan far more than any genomic result available today.
It depends where you sit. Not at low risk, where it rarely reclassifies anyone. Often at borderline risk, where it settles the decision. Reasonable at intermediate risk if you are hesitant about medication. Generally not if your LDL is already 190 or above.
Not necessarily. Between 30 and 59, a 30 year estimate is added when the 10 year figure is low or borderline, because a low short term risk can sit alongside a high lifetime one.
No. Risk thresholds exist to open a discussion, not to end one. People have different thresholds for daily medication and that is a legitimate input. A calcium score often makes the choice clearer either way.
Every four to six years if you are low risk, yearly at borderline or above, and sooner if a risk factor changes or you start medication.
Yes, mainly the targets. A calcium score of 100 to 299 brings an LDL goal under 70 mg/dL and 300 or more a goal under 55, which are the targets used after a heart attack.
Yes. Bring the results, the calculator used and the recommendations. Different calculators give different answers for the same person, and that alone explains many conflicting recommendations.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.